Letter in response to “Our HER2 is same as yours”

Tekijä Matsusaka, Satoshi, Yoshida, Kazuhiro
Julkaisussa Transl Gastroenterol Hepatol (2016)

Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab

Tekijä Osumi, Hiroki, Matsusaka, Satoshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Mizunuma, Nobuyuki
Julkaisussa Onco Targets Ther (2015)

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

Tekijä Sato, Yasuyoshi, Matsusaka, Satoshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Mizunuma, Nobuyuki
Julkaisussa Onco Targets Ther (2015)

Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer

Tekijä Ohhara, Yoshihito, Suenaga, Mitsukuni, Matsusaka, Satoshi, Shinozaki, Eiji, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Julkaisussa Onco Targets Ther (2015)

Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients

Tekijä OSUMI, HIROKI, MATSUSAKA, SATOSHI, WAKATSUKI, TAKERU, SUENAGA, MITSUKUNI, SHINOZAKI, EIIJ, MIZUNUMA, NOBUYUKI
Julkaisussa Mol Clin Oncol (2015)

Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study

Tekijä Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Yamaguchi, Toshiharu
Julkaisussa Drug Des Devel Ther (2015)

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

Tekijä SUZUKI, SHUN-ICHI, MATSUSAKA, SATOSHI, HIRAI, MITSUHARU, SHIBATA, HARUMI, TAKAGI, KOICHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Julkaisussa Int J Oncol (2015)

Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab

Tekijä Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Shinozaki, Eiji, Matsusaka, Satoshi, Ozaka, Masato, Ogura, Mariko, Chin, Keisho, Yamaguchi, Toshiharu
Julkaisussa Onco Targets Ther (2015)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

Tekijä Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Chin, Keisho, Yamaguchi, Toshiharu
Julkaisussa Drug Des Devel Ther (2015)

Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report

Tekijä Osumi, Hiroki, Matsusaka, Satoshi, Shinozaki, Eiji, Suenaga, Mitsukuni, Mingyon, Mun, Saiura, Akio, Ueno, Masashi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Julkaistu 2013

Secondary central nervous system lymphoma surrounding a region injured by subarachnoid hemorrhage and subsequent aneurysmal clipping

Tekijä Murata, Yoriko, Hata, Yasuhiro, Noda, Yoshihiro, Matsusaka, Satoshi, Fukui, Naoki, Kadota, Tomohito, Iwata, Jun, Machida, Takuya, Yamagami, Takuji
Julkaisussa Biomed Rep (2017)

Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of...

Tekijä OBA, MASARU, CHIN, KEISHO, KAWAZOE, YOSHIMASA, TAKAGI, KOICHI, OGURA, MARIKO, SHINOZAKI, EIJI, SUENAGA, MITSUKUNI, MATSUSAKA, SATOSHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Julkaistu 2011

Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens

Tekijä OBA, MASARU, CHIN, KEISHO, KAWAZOE, YOSHIMASA, TAKAGI, KOICHI, OGURA, MARIKO, SHINOZAKI, EIJI, SUENAGA, MITSUKUNI, MATSUSAKA, SATOSHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Julkaistu 2011

Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

Tekijä KUBOKI, YASUTOSHI, MIZUNUMA, NOBUYUKI, OZAKA, MASATO, OGURA, MARIKO, SUENAGA, MITSUKUNI, SHINOZAKI, EIJI, MATSUSAKA, SATOSHI, CHIN, KEISHOU, MATSUURA, MASAAKI, HATAKE, KIYOHIKO
Julkaistu 2011

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chem...

Tekijä Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Kumekawa, Yosuke, Ogura, Mariko, Ozaka, Masato, Matsusaka, Satoshi, Chin, Keisho, Yamamoto, Noriko, Mizunuma, Nobuyuki
Julkaisussa BMC Cancer (2015)

Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy

Tekijä Matsusaka, Satoshi, Kobunai, Takashi, Yamamoto, Noriko, Chin, Keisho, Ogura, Mariko, Tanaka, Gotaro, Matsuoka, Kazuaki, Ishikawa, Yuichi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Julkaisussa Genes Cancer (2016)

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)

Tekijä Suenaga, Mitsukuni, Fujimoto, Yoshiya, Matsusaka, Satoshi, Shinozaki, Eiji, Akiyoshi, Takashi, Nagayama, Satoshi, Fukunaga, Yosuke, Oya, Masatoshi, Ueno, Masashi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Julkaisussa Onco Targets Ther (2015)

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

Tekijä Suenaga, Mitsukuni, Mashima, Tetsuo, Kawata, Naomi, Wakatsuki, Takeru, Horiike, Yuki, Matsusaka, Satoshi, Dan, Shingo, Shinozaki, Eiji, Seimiya, Hiroyuki, Mizunuma, Nobuyuki, Yamaguchi, Kensei, Yamaguchi, Toshiharu
Julkaisussa Oncotarget (2016)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

Tekijä Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Julkaisussa Pharmacogenomics J (2015)

Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer

Tekijä Suenaga, Mitsukuni, Cao, Shu, Zhang, Wu, Matsusaka, Satoshi, Okazaki, Satoshi, Berger, Martin D., Miyamoto, Yuji, Schirripa, Marta, Barzi, Afsaneh, Yamamoto, Noriko, Yamaguchi, Toshiharu, Lenz, Heinz-Josef
Julkaisussa Pharmacogenet Genomics (2021)